Loading...
NPI 1932843836 · Houston, TX · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Elixir Diagnostics, LLC is a clinical medical laboratory provider located in Houston, Texas. This profile covers 47 Medicare and 38 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Elixir Diagnostics, LLC |
| Address | 17115 Red Oak Dr Ste 123 |
| City | Houston |
| State | TX |
| ZIP | 77090 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | April 26, 2022 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $4.1M |
| Medicaid | $360 |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
47 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 98,050 | $10 | $1.2M |
| 81307 | The lab analyst performs the technical lab test on a specimen such as blood, to analyze the entire gene sequence for the partner and localizer of BRCA2 (PALB2) gene. | 520 | $660 | $343.4K |
| 81317 | The lab analyst performs the technical lab test to analyze the entire gene sequence for the postmeiotic segregation increased 2 [S. cerevisiae], or PMS2 gene. | 510 | $660 | $338.1K |
| 81298 | The lab analyst performs the technical lab test to analyze the entire gene sequence for the mutS homolog 6 [E. coli], or MSH6 gene. | 460 | $630 | $291.9K |
| 81419 | The lab analyst performs the technical lab test on a specimen such as blood to conduct a genomic sequence analysis panel. The test evaluates the genetic sequences of at least the 24 genes listed in… | 100 | $2,400 | $240K |
| 81249 | The lab analyst performs the technical lab test to analyze known the full gene sequence of the glucose–6–phosphate dehydrogenase (G6PD) gene. | 340 | $590 | $198.7K |
| 81238 | The lab analyst performs the technical lab test to analyze the full gene sequence of the coagulation factor IX (F9) gene. | 320 | $590 | $186.4K |
| 81223 | The lab analyst performs the technical lab test to analyze the entire gene sequence for cystic fibrosis transmembrane conductance regulator gene, also known as CFTR. | 330 | $490 | $160.9K |
| 81162 | The lab analyst performs the technical lab test to analyze the entire gene sequence for the BRCA1, DNA repair–associated gene, also called BRCA1; and BRCA2, DNA repair–associated gene, also called… | 90 | $1,790 | $159.1K |
| 81201 | The lab analyst performs the technical lab test to analyze the entire gene sequence for adenomatous polyposis coli, also known as APC. | 200 | $760 | $153.6K |
Showing 1–10 of 47
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 47 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
47 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 81185 | 4 | 10 | 110 | $820 | $906.1K |
| 81419 | 4 | 10 | 80 | $2,400 | $666.2K |
| 81325 | 4 | 10 | 90 | $750 | $582.2K |
| 81302 | 3 | 10 | 90 | $520 | $479.9K |
| 81317 | 4 | 20 | 220 | $660 | $382.7K |
| 81298 | 4 | 20 | 220 | $630 | $362.7K |
| 81307 | 3 | 20 | 150 | $660 | $361.4K |
| 81249 | 6 | 20 | 80 | $590 | $319.2K |
| 81238 | 6 | 20 | 110 | $590 | $281.7K |
| 81309 | 4 | 10 | 110 | $270 | $278.9K |
Showing 1–10 of 47
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
38 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 81419 | The lab analyst performs the technical lab test on a specimen such as blood to conduct a genomic sequence analysis panel. The test evaluates the genetic sequences of at least the 24 genes listed in… | 10 | $10 | $100 |
| 81185 | The lab analyst performs the technical lab test to analyze the entire gene sequence for the calcium voltage–gated channel subunit alpha1 A gene, also called CACNA1A. | 10 | $1 | $40 |
| 81321 | The lab analyst performs the technical lab test to analyze the entire gene sequence for the phosphatase and tensin homolog, or PTEN, gene. | 30 | $1 | $30 |
| 81175 | The lab analyst performs the technical lab test to analyze the entire gene sequence for the additional sex combs like 1 (ASXL1), transcriptional regulator gene. | 10 | $1 | $20 |
| 81286 | The lab analyst performs the technical lab test to analyze the entire gene sequence for the frataxin gene (FXN). | 20 | $1 | $20 |
| 81189 | The lab analyst performs the technical lab test to analyze the entire gene sequence for the cystatin B gene (CSTB). | 10 | $1 | $10 |
| 81225 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene for cytochrome P450, family 2, subfamily C, polypeptide 19, also known as CYP2C19. | 10 | $1 | $10 |
| 81226 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene for cytochrome P450, family 2, subfamily D, polypeptide 6, also known as CYP2D6. | 10 | $1 | $10 |
| 81227 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene for cytochrome P450, family 2, subfamily C, polypeptide 9, also known as CYP2C9. | 10 | $1 | $10 |
| 81230 | The lab analyst performs the technical lab test to analyze the common variants of the cytochrome P450 family 3 subfamily A member 4 gene (CYP3A4), such as *2, *22. | 10 | $1 | $10 |
Showing 1–10 of 38
How this provider's Medicaid billing volume and revenue compare to other Texas providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Texas median
38 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 81220 | The lab analyst performs the technical lab test to detect the presence of changes in the gene for cystic fibrosis transmembrane conductance regulator, also known as CFTR. The test evaluates the CFTR… | 20 | 20 | 180 | $200 | $923K |
| 81329 | The lab analyst performs the technical lab test to detect deletions in the survival of motor neuron 1 (SMN1), telomeric, gene and may also analyze the survival of motor neuron 2 (SMN2), centromeric,… | 15 | 20 | 70 | $40 | $178.1K |
| 81243 | The lab analyst performs the technical lab test to detect the presence of changes in the gene for fragile X messenger ribonucleoprotein 1, also known as FMR1, typically to detect common abnormal… | 14 | 20 | 230 | $10 | $53.9K |
| 81185 | The lab analyst performs the technical lab test to analyze the entire gene sequence for the calcium voltage–gated channel subunit alpha1 A gene, also called CACNA1A. | 5 | 10 | 40 | $380 | $45.7K |
| 81302 | The lab analyst performs the technical lab test to analyze the entire gene sequence for the methyl CpG binding protein 2, or MECP2 gene. | 5 | 10 | 30 | $260 | $30.7K |
| 81200 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene for aspartoacylase, also known as ASPA. | 13 | 10 | 170 | $10 | $21.9K |
| 81325 | The lab analyst performs the technical lab test to analyze the entire gene sequence for the peripheral myelin protein 22, or PMP22, gene. | 4 | 10 | 60 | $290 | $21.9K |
| 81255 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene for hexosaminidase A [alpha polypeptide], also known as HEXA. | 14 | 10 | 160 | $10 | $19.6K |
| 81251 | The lab analyst performs the technical lab test to detect the presence of specific changes in the gene for glucosidase, beta, acid, also known as GBA. | 14 | 10 | 130 | $10 | $17.2K |
| 81260 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene for inhibitor of kappa light polypeptide gene enhancer in B–cells, kinase complex–associated… | 13 | 10 | 340 | $10 | $15.5K |
Showing 1–10 of 38
Other providers in the same ZIP code as Elixir Diagnostics, LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Epic Health Services, Inc. | TX | Home Health Agency | $0 | $85.4M |
| Houston Northwest Operating Company, LLC | TX | General Acute Care Hospital | $0 | $18.4M |
| Spring Independent School District | TX | Local Education Agency (LEA) | $0 | $12.2M |
| Rachel Marie Jelks | TX | Community/Behavioral Health Agency | $0 | $11.2M |
| Olympia Jeffries | TX | Nurse Practitioner | $1.4M | $0 |
| Northwest Surgery Center, Ltd | TX | Ambulatory Surgical Clinic/Center | $899.8K | $0 |
| Kirk Kanady | TX | Radiation Oncology Physician | $603.6K | $0 |
| Kozhaya Sokhon | TX | Cardiovascular Disease Physician | $397.7K | $0 |
| Eric Kleinbaum | TX | Hematology & Oncology Physician | $391.1K | $0 |
| Tri Nguyen | TX | Dermatology Physician | $366.7K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.